Lobbying Spend
—
Filings
26
Firms Hired
3
Active Period
2004–2012
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Community-Based Mental Health Infrastructure Improvements Act
2010 · fourth_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal.
Client expense: — · Firm income: $50,000
Matched citations: HR 4899
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · fourth_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal.
Client expense: — · Firm income: $50,000
Matched citations: HR 1706
Preserve Access to Affordable Generics Act
2010 · fourth_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal.
Client expense: — · Firm income: $50,000
Matched citations: S 369
Community-Based Mental Health Infrastructure Improvements Act
2010 · third_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206).
Client expense: — · Firm income: $50,000
Matched citations: HR 4899
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · third_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206).
Client expense: — · Firm income: $50,000
Matched citations: HR 1706
Preserve Access to Affordable Generics Act
2010 · third_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206).
Client expense: — · Firm income: $50,000
Matched citations: S 369
Community-Based Mental Health Infrastructure Improvements Act
2010 · second_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206); HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 (proposed amendments regarding patent settlements); HR 4678 Foreign Manufacturing Legal Accountability Act of 2010
Client expense: — · Firm income: $50,000
Matched citations: HR 4899
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · second_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206); HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 (proposed amendments regarding patent settlements); HR 4678 Foreign Manufacturing Legal Accountability Act of 2010
Client expense: — · Firm income: $50,000
Matched citations: HR 1706
Foreign Manufacturers Legal Accountability Act of 2010
2010 · second_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206); HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 (proposed amendments regarding patent settlements); HR 4678 Foreign Manufacturing Legal Accountability Act of 2010
Client expense: — · Firm income: $50,000
Matched citations: HR 4678
Preserve Access to Affordable Generics Act
2010 · second_quarter · Firm: ALSTON & BIRD LLP
HR 1706 Protecting Consumer Access to Generic Drugs Act; S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206); HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 (proposed amendments regarding patent settlements); HR 4678 Foreign Manufacturing Legal Accountability Act of 2010
Client expense: — · Firm income: $50,000
Matched citations: S 369
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3590
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3962
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3962
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1706
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1706
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 573
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 573
Preserve Access to Affordable Generics Act
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: S. 369
Preserve Access to Affordable Generics Act
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: S. 369
Fair Prescription Drug Competition Act
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: S. 501
Fair Prescription Drug Competition Act
2010 · first_quarter · Firm: ALSTON & BIRD LLP
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
Client expense: — · Firm income: $50,000
Matched citations: S. 501
Revisions to the Medicare Improvement for Patients and Providers Act of 2009, section 203 Pharmacy reimbursement under Medicaid; HR 3962, Affordable Health Care for America Act (Section 1741); HR 3950 Patient Protection and Affordable Care Act (Section 2503)
Client expense: — · Firm income: $50,000
Matched citations: HR 3962
Protecting Consumer Access to Generic Drugs Act of 2009
2009 · fourth_quarter · Firm: ALSTON & BIRD LLP
H.R. 573, Bill to prohibit authorized generics during period of exclusivity S. 501, Fair Prescription Drug Competition Act H.R. 1706, Protecting Consumer Access to Generic Drugs Act S. 369 (Preserve Access to Affordable Generics Act)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1706
Improving Mathematics and Science Teacher Quality Act
2009 · fourth_quarter · Firm: ALSTON & BIRD LLP
Revisions to the Medicare Improvement for Patients and Providers Act of 2009, section 203 Pharmacy reimbursement under Medicaid; HR 3962, Affordable Health Care for America Act (Section 1741); HR 3950 Patient Protection and Affordable Care Act (Section 2503)
Client expense: — · Firm income: $50,000
Matched citations: HR 3950
Source: Senate LDA